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In this issue, van Bueren et al. (2011) take us on a journey from a functional link between the host glycogen-
degrading properties of SpuA and Streptococcus pneumoniae virulence using cell-based studies, to
revealing the structural basis for glycogen recognition and degradation by this S. pneumoniae virulence
factor via complementary X-ray crystallography and small-angle X-ray (SAXS) studies.The efficient degradation of complex
carbohydrates by bacteria is an essential
reaction in nature, such as in the break-
down of dietary sugars and in the turnover
of biomass or the mucosal layer of the gut
(Bayer et al., 1998; Flint et al., 2008). To
perform these functions, bacteria have
evolved to produce members of a super-
family of enzymes termed glycoside
hydrolases (GH) that catalyze the degra-
dation of saccharide moieties through
hydrolytic cleavage of glycosidic bonds
(Zechel and Withers, 2001). What has
also emerged is that the virulence of
many pathogens is associated, at least
in part, to the activities of a subset of
these enzymes. Indeed, sequencing en-
deavours continually reveal that the
genomes of several pathogenic bacteria
encode an extensive array of secreted
GHs, and that these enzymes are
often large (>100 kDa) and typically
display a complex multimodular structure
comprising a catalytic module, predicted
to target host glycans, and numerous
ancillary modules of varying function,
thought to complement and/or modulate
the activity of the enzyme (Ficko-Blean
et al., 2009).
Detailed structure-function studies of
the multimodular GHs have traditionally
been impeded by an inability to generate
full-length recombinant protein in suffi-
cient quantities and the inherent technical
difficulties that their large size and
dynamic properties (e.g., intermodular
linker regions) bring to standard structural
methodologies, such as X-ray crystallog-
raphy andNMR spectroscopy. As a result,
researchers have taken a piecemeal or
dissect-and-build approach, whereby
structure-function models of the full-
length enzymes, including the interplay
between modules, are pieced togetherthrough the structural and functional
characterization of isolated modules.
This approach has met with much
success. Perhaps one of the best exam-
ples involves the carbohydrate-binding
modules (CBMs), which typically accom-
pany the catalytic modules, either as
a single entity or as multiple entities,
frequently in tandem within the GH struc-
ture. Members of this superfamily of
protein modules do not possess catalytic
function themselves, but rather generally
target the GH to a polysaccharide sub-
strate with varying specificities and allow
for rapid degradation by maintaining the
catalytic domain in proximity of substrate
(Boraston et al., 2004).
Unfortunately, the dissect-and-build
approach suffers from some notable limi-
tations, including an inability to provide
detailed information on the spatial ar-
rangement(s) of modules in the full-length
enzymes (e.g., intermodular interactions)
and how they contribute to its overall
function, including substrate-binding
specificity, cooperativity, and optimal
catalytic activity. As such, a gap in our
comprehensive understanding of these
enzymes exists and until recently has rep-
resented a difficult hurdle to overcome.
However, the pairing of genome se-
quencing and robust bioinformatics algo-
rithms has allowed for much more accu-
rate definitions of module boundaries
(Dyson, 2010), which has had a positive
impact on the ability to produce multi-
modular protein constructs in recombi-
nant bacterial systems. In addition, the
use of ligands, inhibitors, or antibodies in
crystallization conditions has augmented
our ability to crystallize complex protein
assemblies. Furthermore, developments
in SAXS technology have facilitated
assessment of protein structure and inStructure 19, May 11, 2011particular, the overall spatial organization
of large, potentially dynamic multimodular
protein assemblies that would otherwise
be recalcitrant to crystallization (Putnam
et al., 2007). Using these methodologies
in combination, and with cell-based func-
tional studies, offers a truly comprehen-
sive approach toward fully characterizing
complex multimodular GHs.
In this context, the structural and func-
tional characterization of the glycogen-
degrading pneumococcal virulence factor
SpuA by van Bueren et al. (2011) repre-
sents a tour de force that illustrates the ro-
bustness of such an approach. Previous
work by this group established that the
hydrolytic activity of SpuA targets the
a-1,6 branch points of glycogen, its
requirement for S. pneumoniae growth
on glycogen, and the high-affinity target-
ing of the N-terminal tandem family 41
CBMs to glycogen of lung tissue (Abbott
et al., 2010; van Bueren et al., 2007).
SpuA had also been identified as a puta-
tive virulence factor (Hava and Camilli,
2002), yet no direct functional studies
had corroborated this finding—that is,
until now. Infected mice showed higher
levels of wild-type S. pneumoniae in lung
and blood as opposed to the deletion
replacement spuA mutant, whereas fluo-
rescence microscopy indicated that
SpuA acts on cytoplasmic sources of
glycogen, and not glycogen granules, in
human alveolar cells. These findings illus-
trate a direct role of SpuA and its
glycogen-degrading properties in
S. pneumoniae virulence.
To complement their functional desig-
nation of SpuA as a virulence factor, the
authors provide a structural rationale for
its glycogen-degrading properties by
determining the X-ray crystal structure of
a SpuA fragment in complex withª2011 Elsevier Ltd All rights reserved 599
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Previewsmaltotetraose. Remarkably, this fragment
comprised the entire full-length enzyme,
with the exception of the N-terminal 134
residues and the C-terminal LPXTG-con-
taining region. The two N-terminal family
41 CBMs form a cap over the catalytic
module, with each bound to a maltooligo-
saccharide moiety, while the intervening
linker region could only be partially
modeled, presumably reflecting its
dynamic conformation. The presence of
two maltotetraose molecules in the active
site of SpuA allowed the authors to
discern the roles of Asp778, Glu807, and
Asp895 as the catalytic nucleophile, the
acid/base residue, and the 1 subsite-
stabilizing residue, respectively, which
they also supported with function assays.
Shrewdly, the SpuA structure was also
solved in the presence of a known inhib-
itor 4-O-a-D-glucopyranosylmoranoline
to support the engagement of the malto-
tretraose molecule by the active site
residues.
The positioning of the first family 41
CBM (CBM41-1) proximal to the SpuA
active site is arguably the most intriguing
observation in the structure, since it
represents a novel CBM function that
significantly departs from accepted CBM
dogma. The tryptophan residues of the
carbohydrate-binding site in CBM41-1
contribute directly to the conformation of
the substrate-binding subsites 3 and
4. In an elegant set of kinetic and degra-
dation product analysis studies to test this
structural observation, the authors use
the traditional a-amylase substrate para-
nitrophenyl-a-D-maltopentaoside (pNP-
M5), which should occupy subsite 3
and4 of the active site, and a novel tran-
sition-state mimic inhibitor comprising
maltotetraose and an O-(D-glucopyrano-
sylidene)amino N-phenylcarbamate
(PUGMAL) at the reducing terminus,
which the authors expressly designed
and synthesized for this study. Compar-
ison of the kinetic properties of SpuA
and a SpuA-truncated derivative lacking
both of the CBM41 modules revealed
a 6-fold change in KM for pNP-M5, sug-
gesting that the loss of the 3 and 4600 Structure 19, May 11, 2011 ª2011 Elsevipositions provided by CBM41-1 compro-
mised the carbohydrate recognition by
SpuA. Comparison of the degradation
products of glycogen by SpuA and SpuA
lacking both CBM41s indicated that the
CBMs participate in glycan degradation
and product release, which further
augments the structural implications for
CBM41 as an active participant in the
catalytic activity of SpuA through active
site formation.
Interestingly, the positioning of CBM41-
1 in the structure of SpuA would block
a substrate from extending beyond the
4 subsite, which led the authors to
suggest that there must be conforma-
tional flexibility of the CBMs within the
enzyme to accommodate the substrate
in the active site. Consistent with these
types of dynamic properties, crystalliza-
tion of SpuA in the absence of substrate
or inhibitor proved futile. Consequently,
as an alternative to address this hypoth-
esis, the authors performed SAXS
studies. Since the complexed SpuA
crystal structure modeled poorly to the
SAXS data, an alternative strategy
involved generating two rigid bodies
from the crystallographic coordinates
and either fitting them to the ab initio
envelope or using them in the ensemble
optimization method to account for
a high degree of conformational flexibility
of SpuA in solution. In both cases, the
data best fit models in which the active
site is much more open, supporting the
suggestion that the tandem CBM41s can
adopt a variety of positions relative to
the catalytic module in the absence of
substrate. Unfortunately, clear evidence
of the substrate-bound enzyme consis-
tent with a generally closed conformation
by SAXS, which would allow for direct
comparison with the free SpuA SAXS
data, proved to be much more difficult
to observe. The excess maltotetraose
present in the SpuA samples led to
substantial background scattering, lim-
iting the comprehensive analysis and
interpretation of the data. This illustrates
that although SAXS is emerging as a valu-
able and complementary method for as-er Ltd All rights reservedsessing protein structure and confor-
mational alternations, there remain
technical limitations that may or may not
be overcome.
In summary, this elegant study, both in
breadth and in depth, provides detailed
insight into the mechanism of a virulence
factor from a pathogenic bacterium that
represents a substantial health concern.
Notably, the work illustrates for the first
time the direct and novel contribution of
a CBM to the formation of an active site.
Moreover, this study has provided an
overall scientific approach for the com-
prehensive structural and functional char-
acterization of multimodular carbohy-
drate-active enzymes, one which will
hopefully be emulated by other scientists
when undertaking such an intricate and
timely topic of research.REFERENCES
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